Default: Alzheimer Disease and Associated Disorders

ISSN: 0893-0341

Journal Home

Journal Guideline

Alzheimer Disease and Associated Disorders Q2 Unclaimed

Lippincott Williams and Wilkins Ltd. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Alzheimer Disease and Associated Disorders is a journal indexed in SJR in Psychiatry and Mental Health and Clinical Psychology with an H index of 109. It has an SJR impact factor of 0,609 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,609.

Alzheimer Disease and Associated Disorders focuses its scope in these topics and keywords: alzheimer, impairment, cognitive, disease, mild, framingham, gait, hippocampal, hyperintensities, frontal, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Metrics

Alzheimer Disease and Associated Disorders

0,609

SJR Impact factor

109

H Index

64

Total Docs (Last Year)

191

Total Docs (3 years)

1832

Total Refs

341

Total Cites (3 years)

185

Citable Docs (3 years)

1.64

Cites/Doc (2 years)

28.63

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


alzheimer, impairment, cognitive, disease, mild, framingham, gait, hippocampal, hyperintensities, frontal, insulinrelated, kingdevick, levels, life, matter, mci, midlife, normal, flow, factors, cerebral, cognition, conversion, cornellbrown, correlated, criteria, dementia, dementiarelation, dementiathe, dietary, diseaseprimary, disturbance, elderspostural, factor,



Best articles by citations

Magnetic Resonance in Dementia

View more

Cholinesterases and the Pathology of Alzheimer Disease

View more

Younger Age at Crisis Following Parental Death in Male Children and Adolescents Is Associated With Higher Risk for Dementia at Old Age

View more

Validity of Death Certificate and Hospital Discharge ICD Codes for Dementia Diagnosis

View more

Effectiveness of a Psychoeducational Intervention Group Program in the Reduction of the Burden Experienced by Caregivers of Patients With Dementia

View more

Harmonization of Dementia Drug Guidelines (United States and Europe): A Report of the International Working Group for the Harmonization for Dementia Drug Guidelines

View more

Proxy Decision Making in Alzheimer Disease Research

View more

Screening for Cognitive Impairment in General Practice

View more

Introduction

View more

Anosognosia in Alzheimer Disease

View more

Effect of a Combined Walking and Conversation Intervention on Functional Mobility of Nursing Home Residents With Alzheimer Disease

View more

Age at Onset and Visuocognitive Disturbances in Alzheimer Disease

View more
SHOW MORE ARTICLES

Theory of Mind and Recognition of Facial Emotion in Dementia

View more

Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI

View more

Alzheimer Disease: Absolute Quantification of Cerebral Metabolites In Vivo Using Localized Proton Magnetic Resonance Spectroscopy

View more

Alzheimer Disease: Current Therapy and Future Therapeutic Strategies

View more

Determining the Competency of Alzheimer Patients to Consent to Treatment and Research

View more

Health-Related Quality of Life for Caregivers of Patients With Alzheimer Disease

View more

Medicare Expenditures Associated with Alzheimer Disease

View more

Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Tolerability of Metrifonate in Patients with Probable Alzheimer Disease

View more

Current Status of Clinical Trials for Alzheimer-Type Dementia in Japan: Strategies to Facilitate the Development of Antidementia Drugs

View more

Autopsy Practices at CERAD and Alzheimer Disease Center Sites

View more

Autopsy Recruitment Program for African Americans

View more

The Rest-Activity Rhythm and Physical Activity in Early-Onset Dementia

View more

FAQS